Preliminary Program June 25

Time

---

13:00-14:00

Hall 1

---

Opening ceremony

Welcome
Michael Roden, Spokesman for the Board, Scientific Executive Director,
German Diabetes Center (Düsseldorf, Germany)

Greetings from Representatives
Ina Brandes (via video), Minister of Culture and Science of North Rhine-Westphalia (Düsseldorf, Germany)

Miriam Koch, Deputy Mayor for Culture and Integration Düsseldorf (Germany)

Prof. Dr. Anja Steinbeck, President Heinrich Heine University (Düsseldorf, Germany)

Prof. Dr. Nikolaj Klöcker, Dean Medical Faculty, Heinrich Heine University (Düsseldorf, Germany)

Prof. Dr. Kirsten Schmieder, Medical Director and CEO University Hospital Düsseldorf (Germany)

---

Jühling Prize Ceremony*

Introduction and Laudatio
Michael Roden (Düsseldorf, Germany)

---

Jühling Prize and Jühling Lecture*

Péter Kempler (Budapest, Hungary)
A short journey to no man’s land

---

Jühling Award 2025: Report*

Georgia Xourafa, Rita Vesce
(both Düsseldorf, Germany)

Jühling Award 2026*

---

*A Jühling Foundation event

Hall 2

---

Time

---

14:00-15:00

Hall 1

---

Session 1: CEDA/EASD Symposium

Chairs: Michael Roden (Düsseldorf, Germany), Anca Pantea-Stoian (Bucharest, Romania)

---

Francesco Giorgino (Bari, Italy)
Impact of obesity on development and progression of type 2 diabetes

Hindrik Mulder (Lund, Sweden)
Translating genetic signals into the pathophysiology of type 2 diabetes

Patrick Schrauwen (Düsseldorf, Germany)
Chronobiology and type 2 diabetes: does time matter?

Hall 2

---

Session 2: Diabetes Technology

Chairs: Helmut Schatz (Bochum, Germany), Andrej Janez (Ljubljana, Slovenia)

---

Latife Bozkurt (Vienna, Austria)
Continuous glucose monitoring and hybrid closed-loop systems in pregnancy with type 1 diabetes

Julia Mader (Graz, Austria)
Beyond Glucose: Emerging Biosensors for Comprehensive Metabolic Monitoring

Tim Heise (Neuss, Germany)
New developments in insulin formulations

Time

---

15:30-17:00

Hall 1

---

Session 3: Steatotic Liver Disease

Chairs: Francesco Giorgino (Bari, Italy), Sabine Kahl (Düsseldorf, Germany)

---

Eckhard Lammert (Düsseldorf, Germany)
Novel pathophysiology: MASLD and angiokines

Michael Roden (Düsseldorf, Germany)
Detecting and phenotyping MASLD

Dídac Mauricio (Barcelona, Spain)
Multifactorial approach to MASH

Christos Mantzoros (Boston, USA)
Diabetes and MASLD: the central role of the diabetologist

Hall 2

---

Session 4: Type 1 Diabetes

Chairs: Julia Mader (Graz, Austria), Lukasz Szczerbinski (Bialystok, Poland; Boston, USA)

---

Clara Möser (Düsseldorf, Germany)
From Physiology to Algorithms: Managing Exercise in Type 1 Diabetes

Tomasz Klupa (Krakow, Poland)
Continuous glucose monitoring: does the quality of the device matter?

Thomas Meissner (Düsseldorf, Germany)
Adherence in adolescents with type 1 diabetes: how to enhance engagement

Reinhard Holl (Ulm, Germany)
Heterogeneity of type 1 diabetes

Time

---

17:00-18:00

Hall 1

---

Industry Session 1:  Novo Nordisk Pharma GmbH

Decoding Fat: Implications for Morbidities and Health Outcomes in Clinical Practice

Chair: Michael Roden (Düsseldorf, Germany) 

Robert Wagner (Düsseldorf, Germany)
Beyond weight: Body fat distribution in Diabetes and metabolic health

Oana-Patricia Zaharia (Düsseldorf, Germany)
Role of adipose tissue for cardiovascular health in Diabetes 

Gidon Bönhof (Düsseldorf, Germany)
Decoding Polyneuropathy: The Impact of Adipose Tissue and Inflammatory Responses 

Hall 2

---

Time

---

18:00-19:00

Hall 1

---

Industry Session 2: Lilly Deutschland GmbH

Beyond Metabolism: The Next Era of Therapeutics

Chair: Manfredi Rizzo (Palermo, Italy)

Susanne Reger-Tan (Bad Oeynhausen, Germany)
Simplifiying metabolic care: oral Incretins as first line solution

Timo Müller (Munich, Germany)
Innovative molecules for metabolic medicine: Incretins & beyond

Hall 2

---